MIR1302-5: A Drug Target / Disease Biomarker (G100302146)
MIR1302-5: A Drug Target / Disease Biomarker
MIR1302-5 is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the Mir1 family of transmembrane proteins, which are known for their role in cell signaling.
One of the main functions of MIR1302-5 is its role in cell signaling. MIR1302-5 has been shown to play a role in the regulation of cellular processes such as cell growth, differentiation, and survival.
MIR1302-5 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, studies have shown that MIR1302-5 is overexpressed in various types of cancer, and that inhibiting its activity may be a potential therapeutic approach.
In addition to its role in cell signaling and cancer development, MIR1302-5 has also been shown to be involved in the regulation of inflammation. MIR1302-5 has been shown to play a role in the regulation of immune cells, and has been shown to contribute to the immune response in various organisms.
MIR1302-5 has also been shown to have potential as a drug target. Several studies have shown that MIR1302-5 can be targeted by small molecules, and that these molecules may have therapeutic potential for various diseases. For example, studies have shown that MIR1302-5 is a potential target for cancer, and that inhibiting its activity may be a potential therapeutic approach.
In conclusion, MIR1302-5 is a protein that is expressed in various tissues of the body and is involved in a variety of cellular processes, including cell signaling and cancer development. It is also involved in the regulation of inflammation and has potential as a drug target. Further research is needed to fully understand the role of MIR1302-5 in these processes and to develop effective therapeutic approaches for its use.
Protein Name: MicroRNA 1302-5
The "MIR1302-5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1302-5 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A
